Financhill
Back

Sonnet BioTherapeutics Holdings Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison

Sell
3

SONN
Sonnet BioTherapeutics Holdings

Last Price:
0.93
Seasonality Move:
-22.91%
Buy
55

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
45.13
Seasonality Move:
-11.02%
Sell
3
Sonnet BioTherapeutics Holdings (SONN) is a Sell

Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?

  • The current Sonnet BioTherapeutics Holdings [SONN] share price is $0.94. The Score for SONN is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • SONN is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP) is a Buy

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $45.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SONN Stock Price Chart

What is Sonnet BioTherapeutics Holdings's stock price today?

  • The Sonnet BioTherapeutics Holdings share price today is $0.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing slight selling pressure.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $45.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.

SONN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 26.16 Sell
Chaikin Money Flow: -3019 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.13 - 1.79) Sell
Bollinger Bands (100): (1.47 - 2.01) Sell

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 51.62 Buy
Chaikin Money Flow: 1520753 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.2 - 48.24) Buy
Bollinger Bands (100): (31.14 - 46.02) Buy

SONN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.03 Sell
20-day SMA: 1.43 Sell
50-day SMA: 1.63 Sell
200-day SMA: 1.79 Sell
8-day EMA: 1.07 Sell
20-day EMA: 1.32 Sell
50-day EMA: 1.55 Sell
200-day EMA: 4.55 Sell

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.66 Buy
20-day SMA: 45.82 Sell
50-day SMA: 42.78 Buy
200-day SMA: 22.9 Buy
8-day EMA: 44.51 Buy
20-day EMA: 44.85 Buy
50-day EMA: 42.76 Buy
200-day EMA: 28.27 Buy

Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.04 per share, and a decrease next year of $0.38 per share.

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.70 per share, an increase next quarter of $0.13 per share, an increase this year of $5.96 per share, and an increase next year of $0.18 per share.

Sonnet BioTherapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):